Natera Inc at Morgan Stanley Global Healthcare Conference Transcript
Hey guys. Good afternoon. My name is Tejas Savant, and I'm the life science tools and diagnostics analyst here at Morgan Stanley. It's my pleasure this afternoon to host Natera. And from the company, we have Steve Chapman, CEO; and Mike Brophy, CFO. Thanks, guys, for doing this.
Before we get started, just got to rattle off the disclosures here. Please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your sales rep.
Questions & Answers
So with that, Steve, maybe just to set the stage, it's been quite a year for Natera. You are in the headlines for all the wrong reasons earlier in the year. But through it all, you've continued to execute really well on the base business and on the pipeline. And recently, you've got the United decision as well on the PLN. As you look back on a pretty eventful 12 months, what
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
